Adobe鈥檚 new Email Designer addresses content delays with cloning, GenStudio integration, and improved reuse鈥攕treamlining production for time-starved teams.
Kohl鈥檚 beat Q1 expectations, but challenges remain: The struggling retailer is focused on improving its assortment, establishing value and quality leadership, and offering a seamless customer experience.
The era of tariff-driven trade uncertainty is far from over: A flurry of legal decisions have thrown the administration鈥檚 trade policies into limbo, even as many duties remain firmly in place.
Senate leader questions pharma advertising oversight amid growing calls for more regulation: The threats of new legislation and regulations indicate the seriousness of both the Trump administration and Congress to move against pharma ads.
Best Buy will stick to its tariff playbook despite court rulings: The retailer is doing its best to ignore the noise and focus on how best to serve its customers.
Trump administration drops Moderna mRNA pandemic flu research: This adds to increasing doubt around the validity of mRNA vaccines, and will likely cause uncertainty for drugmakers looking to federal agencies for vaccine guidance.
Potential tariffs, drug pricing order may not be too disruptive to pharma: However, the administration鈥檚 executive orders, proposals, and threats can鈥檛 be taken lightly. Drug companies must stay nimble with plans in place for different outcomes.
Healthcare costs for Americans who have employer-sponsored health insurance spike 7% annually: Employers will need to be more restrictive with their plan offerings, creating an opportunity for D2C healthcare brands to reel in new customers.
Nvidia woos global AI partners, HP shifts output to Mexico and Vietnam, and Lenovo pivots to India鈥攃lear signs that risk mitigation now outweighs China鈥檚 diminishing cost advantage.